Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Rectal Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Melanoma 1Medulloblastoma 1Familial ependymoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Astrocytoma 1

Interventions

Carboplatin 3etoposide phosphate 2Topotecan 2Ifosfamide 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Cyclophosphamide 2transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1sodium thiosulfate 1sargramostim 1Thiotepa 1Stem Cell Transplantation 1Semaxinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Microarray Analysis 1Mesna 1Melphalan 1Mannitol 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Dexamethasone 1Dasatinib 1Cyproheptadine 1Calcium Dobesilate 1Busulfan 1Blotting, Western 1Acetylcysteine 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Familial ependymoma × Semaxinib × Clear all
NCT00006247 2009-10-14

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Pediatric Brain Tumor Consortium

Phase 1 Terminated
33 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡